A resolution supporting the goals and ideals of "Deep Vein Thrombosis and Pulmonary Embolism Awareness Month".
This is a United States Senate resolution (S. Res. 138) that expresses formal support for the goals and ideals of a designated Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) Awareness Month. Sponsored by Senators Grassley, Blunt Rochester, Marshall, and Lujan, the resolution states that the Senate supports efforts to raise public and professional awareness about DVT and PE, including their risks, prevention, and treatment. The measure is non-binding and symbolic in nature; it does not create new programs, funding, or regulatory requirements, but it signals congressional backing for education and awareness activities related to these conditions. The resolution underscores that many DVT/PE events are preventable and emphasizes the importance of awareness for patients, caregivers, and healthcare providers. The document also highlights key statistics and risk factors to frame the issue for public understanding: DVT involves blood clots in deep veins (commonly in the leg) and PE occurs when a clot travels to the lungs. It notes the health impact (up to about 900,000 affected annually in the U.S.; 60,000–100,000 deaths per year; significant hospital mortality related to these conditions) and economic burden (up to $10 billion in incremental medical costs annually). It also identifies groups at higher risk (pregnant individuals, cancer patients, those who are immobile, people undergoing surgery, older adults, and individuals with a family history of clotting disorders) and points to the preventable nature of many cases.
Key Points
- 1The resolution non-verbally expresses Senate support for the goals and ideals of Deep Vein Thrombosis and Pulmonary Embolism Awareness Month.
- 2It recognizes the importance of raising awareness about DVT and PE, including signs, risks, prevention, and treatment.
- 3It presents key statistics: up to 900,000 people affected in the U.S. annually; 60,000–100,000 deaths per year; about 1 in 4 PE deaths occur without warning; and up to $10 billion in incremental medical costs each year.
- 4It identifies major risk factors and vulnerable groups: pregnancy-related risk (including up to 3 months postpartum); cancer; immobility; surgery; older age; and family history of clotting disorders.
- 5It emphasizes that many DVT/PE deaths are preventable and that awareness can help reduce preventable hospital deaths.